Incidentally Found Medullary Thyroid Cancer: Treatment Rationale for Small Tumors

World Journal of Surgery

Volumn 28, Issue 4, 2004, Pages 397-401

  Raffel, Andreas ^a   Cupisti, Kenko ^a   Krausch, Markus ^a   Wolf, Achim ^a   Schulte, Klaus Martin ^a   Röher, Hans Dietrich ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CARCINOEMBRYONIC ANTIGEN; PENTAGASTRIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MALE; NECK DISSECTION; POSTOPERATIVE PERIOD; PROVOCATION TEST; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADULT; AGED; CARCINOMA, MEDULLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 1942508669     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-003-7121-6     Document Type: Article

References (30)

1. Saad MF, Ordonez NG, Rashid RK, et al. Medullary carcinoma of the thyroid: a study of clinical features and prognostic factors in 161 patients. Medicine (Baltimore). 1984;63:319-342
2. Raue F. Epidemiology of medullary thyroid carcinoma: recent results. Cancer Res. 1992;125:47-54
3. Giuffrida D, Gharib H. Current diagnosis and management of medullary thyroid carcinoma. Ann. Oncol. 1998;9:695-701
4. Kebebew E, Ituarte PHG, Siperstein AE, et al. Medullary thyroid carcinoma. Cancer 2000;0:1139-1148
5. Moley JF, Dilley WG, DeBenedetti MK. Improved results of cervical reoperation for medullary thyroid carcinoma. Ann. Surg. 1997;225:734-743
6. Gimm O, Sutter T, Dralle H. Diagnosis and therapy of sporadic and familial medullary thyroid carcinoma. J. Cancer Res. Clin. Oncol. 2001;127:156-165
7. Mulligan LM, Kwok JB, Healey CS, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993;363:458-460
8. Hofstra RM, Landsvater RM, Ceccherini I, et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994;367:375-376
9. Moley JF. Medullary thyroid cancer. Surg. Clin. North Am. 1995;75:405-420
10. Wells SA, Franz C. Medullary carcinoma of the thyroid gland. World J. Surg. 2000;24:952-956
11. Kaserer K, Scheuba C, Neuhold N, et al. C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. Am. J. Surg. Pathol. 1998;22:722-728
12. Dralle H. Lymph node dissction and medullary thyroid carcinoma. Br. J. Surg. 2002;89:1073-1075
13. Colombo-Benkmann M, Raff J, Raue F, et al. Effect of primary surgical therapy on the course of C-cell carcinoma of the thyroid gland. Langenbecks Arch. Chir. Suppl. Kongressbd. 1998;115:1041-1043
14. Marsh DL, Learoyd DL, Robinson BG. Medullary thyroid carcinoma: recent advances and management update. Thyroid 1995;5:407-424
15. Heshmati HM, Gharib H, van Heerden JA, et al. Advances and controversies in the diagnosis and management of medullary thyroid carcinoma. Am. J. Med. 1997;103:60-69
16. Gimm O, Ukkat J, Dralle H. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. World J. Surg. 1998;22:562-568
17. Beressi N, Campos JM, Beressi JP, et al. Sporadic medullary microcarcinoma of the thyroid: a retrospective analysis of eight cases. Thyroid 1998;8:1039-1044
18. Grundmann E, Hermanek P, Wagner G. Tumor histological key: the new 1997 edition; German language morphological section of the ICD-O. Pathologe 1997;18:493-498
19. Berndt I, Reuter M, Saller B, et al. A new hotspot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple neoplasia type 2A. J. Clin. Endocrinol. Metab. 1998;83:770-774
20. Miyauchi A, Matsuzuka F, Hirai K, et al. Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma. World J. Surg. 2000;24:1367-1372
21. Cupisti K, Simon D, Wolf A, et al. Surgical treatment of postoperative, incidentally diagnosed small sporadic C-cell carcinomas of the thyroid. Langenbecks Arch. Surg. 2000;385:526-530
22. Miyauchi A, Matsuzuka F, Keisuke H, et al. Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations. World J. Surg. 2002;26:1023-1028
23. Kallinowski F, Buhr HJ, Meybier H, et al. Medullary carcinoma of the thyroid-therapeutic strategy derived from fifteen years of experience. Surgery 1993;114:491-496
24. Pacini F, Fontanelli M, Fugazolla L, et al. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma, J. Clin. Endocrinol. Metab. 1994;78:826-829
25. Wagner HE, Ruchti C, Studer M, et al. Langzeitverlauf des medullôren Schilddrüsenkarzinoms. Swiss Surg. 1996;2:181-186
26. Niccoli P, Wion-Barbot N, Caron P, et al. Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. J. Clin. Endocrinol. Metab. 1997;82:338-341
27. Henry JF, Denziot A, Puccini M, et al. Latent subclinical medullary thyroid carcinoma: diagnosis and treatment. World J. Surg. 1998;22:752-757
28. Goretzki PE, Simon D, Frilling A, et al. Surgical reintervention for differentiated thyroid cancer. Br. J. Surg. 1993;80:1009-1012
29. Pezullo L, Delrio P, Losito NS, et al. Post-operative complications after completion thyroidectomy for differentiated thyroid cancer. Eur. J. Surg. Oncol. 1997;23:215-218
30. Gimm O, Dralle H. Reoperation in metastasizing medullary thyroid carcinoma: is a tumor stage-oriented approach justified? Surgery 1997;122:1124-1131